In vitro and in vivo comparability assessment of an AAV vector manufactured by triple transfection in HEK293 cells or in the baculovirus expression system

被引：0
|
作者：
Steel, M.
Woodburn, K.
Kniffin, T.
Gebretsadik, K.
Chan, J.
Vijay, S.
Chen, H.
Chalberg, T. W.
Gasmi, M.
机构：
[1] Avalanche Biotechnol, Menlo Pk, CA USA
[2] Virovek Inc, Hayward, CA USA
来源：
HUMAN GENE THERAPY | 2015年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P147
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 47 条
  • [1] Biophysical and In Vitro Comparability Analysis of an AAV Vector Produced by the Baculovirus/Sf9 System and HEK Triple Transfection System
    Horowitz, Eric D.
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 49 - 49
  • [2] Analytical comparison of AAV manufactured by triple-plasmid transfection/HEK293 and double-baculovirus infection/SF9 processes
    Ng, M.
    Nelson, S.
    Kakkar, S.
    Arnaout, A.
    Fenn, T.
    Danniels, G.
    Zhou, J.
    Raut, P.
    Daniels, C.
    Higgins, L.
    Kamalakaran, S.
    Dai, Y.
    Hayashi, M. L.
    Haller, J. F.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A35 - A35
  • [3] Vector Engineering of pRep-Cap and pHelper Enhanced AAV Productivity by Triple Transfection in Suspension HEK293 Cells
    Tripp, Caitlin
    Wang, Jennifer
    Chen, Tsai-Yu
    Dong, Wenling
    Ramaswamy, Senthil
    Gu, Bingnan
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 62 - 62
  • [4] Extensive comparison of HEK293 transfection process and Baculovirus expression system to manufacture an AAV8-based treatment for Crigler-Najjar syndrome
    Guianvarc'h, L.
    Collaud, F.
    Le Bec, C.
    Mingozzi, F.
    Mavilio, F.
    Hebben, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A25 - A25
  • [5] AAV Packaging in HEK293 Cells Prefers Unit-Length Vector Genomes
    Li, Xin
    Miller, Lohra Mickelle
    Frabutt, Dylan A.
    Lam, Anh K.
    Draper, Benjamin E.
    Jarrold, Martin F.
    Herzog, Roland W.
    Xiao, Weidong
    Zhang, Junping
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 506 - 507
  • [6] Development and upscale of HEK293 triple transfection process in single-use bioreactors for industrial manufacture of AAV vectors
    Guianvarc'h, L.
    Boussicault, F.
    Le Bec, C.
    Mingozzi, F.
    Mavilio, F.
    Hebben, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A70 - A71
  • [7] Study on vector elements for efficient selection, expression and secretion in HEK293 cells
    Roman, Ramon
    Miret, Joan
    Martinez, Ivan
    Roura, Aida
    Casablancas, Antoni
    Lecina, Marti
    Cairo, Jordi J.
    [J]. NEW BIOTECHNOLOGY, 2016, 33 : S189 - S189
  • [8] Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities
    Moco, Pablo D.
    Xu, Xingge
    Silva, Cristina A. T.
    Kamen, Amine A.
    [J]. BIOTECHNOLOGY JOURNAL, 2023, 18 (09)
  • [9] Resistance is futile: evaluating and modifying cellular pathways during AAV vector expression in HEK293 cells to increase viral titers
    Kraemer, N.
    Teschner, K.
    Ortseifen, V.
    Sundermann, F.
    Droste, J.
    Northoff, S.
    Klausing, S.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A153 - A154
  • [10] High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
    Subedi, Ganesh P.
    Johnson, Roy W.
    Moniz, Heather A.
    Moremen, Kelley W.
    Barb, Adam
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (106):
12345